Product nameAnti-MSC antibody
See all MSC primary antibodies
DescriptionRabbit polyclonal to MSC
SpecificityDetects endogenous levels of total MSC protein.
Tested applicationsSuitable for: WB, IHC-P, ELISAmore details
Species reactivityReacts with: Human
Predicted to work with: Mouse
Synthetic peptide from internal of human Musculin.
- Human lymph node tissue and Jurkat cell extract
Storage instructionsShipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.
Storage bufferpH: 7.40
Preservative: 0.02% Sodium azide
Constituents: PBS, 50% Glycerol, 0.87% Sodium chloride
Without Mg2+ and Ca2+
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab64954 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/500 - 1/1000. Detects a band of approximately 22 kDa (predicted molecular weight: 22 kDa).|
|IHC-P||1/50 - 1/100.|
FunctionTranscription repressor capable of inhibiting the transactivation capability of TCF3/E47. May play a role in regulating antigen-dependent B-cell differentiation.
Tissue specificityExpressed in lymphoid tissues, B-cell lines and activated B-cells.
Sequence similaritiesContains 1 basic helix-loop-helix (bHLH) domain.
- Information by UniProt
- ABF-1 antibody
- ABF1 antibody
- Activated B cell factor 1 antibody
All lanes : Anti-MSC antibody (ab64954) at 1/500 dilution
Lane 1 : Jurkat cell extract
Lane 2 : Jurkat cell extract with immunising peptide at 10 µg
Lysates/proteins at 30 µg per lane.
Predicted band size: 22 kDa
Observed band size: 22 kDa
Immunohistochemical analysis of paraffin-embedded human lymph node tissue using ab64954 at 1/50-1/100 dilution. The right hand panel was also treated with the immunising peptide.
This product has been referenced in:
- Jorge ML et al. The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus. Metabolism 60:1244-52 (2011). Read more (PubMed: 21377179) »